Rocket Pharmaceuticals Inc header image

Rocket Pharmaceuticals Inc

RCKT

Equity

ISIN null / Valor 39764376

NASDAQ (2026-06-03)
USD 2.92+1.04%

Rocket Pharmaceuticals Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Rocket Pharmaceuticals Inc. is a New York–based, Nasdaq‑listed clinical‑stage biotechnology company developing gene therapies for rare, inherited pediatric diseases. The firm advances both ex vivo lentiviral approaches—principally via genetically modified hematopoietic stem cells—and in vivo AAV‑based therapies, with clinical programs targeting hematologic, neuromuscular and cardiac genetic disorders. In addition to advancing multiple clinical candidates, Rocket operates internal vector manufacturing and development capabilities to support its trials and regulatory filings, positioning itself as a developer of durable, one‑time genetic interventions for severe monogenic conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-1.35%1Y
-86.6%3Y
-93.1%5Y

Performance

128%1Y
90.3%3Y
85.0%5Y

Volatility

Market cap

319 M

Market cap (USD)

Daily traded volume (Shares)

2,896,142

Daily traded volume (Shares)

1 day high/low

12.25 / 11.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
2.00
Nature:
starstarstarstarstar
2.00
Pascale Gonzalez
Switzerland, 16 Apr 2025
star star star star star
So la la

EQUITIES OF THE SAME SECTOR

Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.34%USD 25.57
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.73%EUR 48.70
Formycon AG
Formycon AG Formycon AG Valor: 12194189
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.74%EUR 20.05
Bright Horizons Family Solutions
Bright Horizons Family Solutions Bright Horizons Family Solutions Valor: 19920287
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.28%USD 59.64
Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.74%USD 65.88
AMN Healthcare Services Inc
AMN Healthcare Services Inc AMN Healthcare Services Inc Valor: 1269241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.20%USD 30.31
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.30%CHF 4.05
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.24%CHF 339.00
Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.03%USD 21.46
RHOEN-KLINIKUM AG
RHOEN-KLINIKUM AG RHOEN-KLINIKUM AG Valor: 341644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 12.30